Medill Pharma Private Limited
About Medill Pharma Private Limited
Data last updated:
Medill Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 30 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33309RJ2019PTC081242. Its GSTIN is 08AAMCM7104Q1ZU (Rajasthan). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anish Verma and Vinod Vijay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101/31 Pratap Nagar Sanganer, Jaipur, Rajasthan, India – 302033.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹5.36 Lakh (net margin 5.2%) and EBITDA of ₹6.96 Lakh (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 41% over five years.
Company details
CIN history
Medill Pharma has one previous CIN (Corporate Identification Number): U33309GJ2019PTC108437. The current CIN is U33309RJ2019PTC081242, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33309RJ2019PTC081242 | Current |
| U33309GJ2019PTC108437 | Previous |
Contact details
Medill Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address101/31 Pratap Nagar Sanganer, Jaipur, Rajasthan, India – 302033
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Medill Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medill Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medill Pharma Private Limited, buy the company report.
Financials of Medill Pharma Private Limited
FY 2025 filings availableMedill Pharma Private Limited reported revenue of ₹1.03 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 23% growth in the latest year. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.96 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medill Pharma Private Limited, buy the company report.
Board of directors of Medill Pharma Private Limited
Medill Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anish Verma | Director | 17 Feb 2021 | 5 Years 8 Months | Current |
| Vinod Vijay | Director | 17 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Medill Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Niyamba Pharmaceutical Private Limited | ₹1.03 Cr (FY 2025) | 2.0% | Satna, Madhya Pradesh, India | |||
| Pfleger Healthcare Private Limited | ₹1.03 Cr (FY 2025) | 38.0% | Nashik, Maharashtra, India | |||
| Medill Pharma Private Limitedthis company | ₹1.03 Cr (FY 2025) | ₹5.36 Lakh | 5.2% | 23.0% | Jaipur, Rajasthan, India | |
| Pusilin Biotechnology Private Limited | ₹1.03 Cr (FY 2024) | -83.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Medill Pharma Private Limited, buy the company report.
Auditor
Medill Pharma Private Limited is audited by ARPITVIJAY&COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARPITVIJAY&COMPANY | FY 2023 | 017737C |
Shareholding
The shareholding of Medill Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Medill Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medill Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medill Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medill Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAMCM7104Q1ZU | Rajasthan | Active | 12 Jul 2019 |
| 24AAMCM7104Q1Z0 | Gujarat | Active | 28 Jan 2026 |
To see the full GST registrations and return filing status of Medill Pharma Private Limited, buy the company report.
Recent activity
Medill Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Tej Singh ceased to be Director on 19 Feb 2021.
Frequently asked questions
Medill Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 30 May 2019 (7+ years old) and is registered under CIN U33309RJ2019PTC081242.
Medill Pharma has 2 current directors:
- Anish Verma - Director
- Vinod Vijay - Director
The latest financial statements of Medill Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medill Pharma is 08AAMCM7104Q1ZU, registered in Rajasthan. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAMCM7104Q1Z0 (Gujarat).
The CIN (Corporate Identification Number) of Medill Pharma is U33309RJ2019PTC081242. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medill Pharma was incorporated on 30 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Medill Pharma by revenue are Niyamba Pharmaceutical Private Limited, Pfleger Healthcare Private Limited, Pusilin Biotechnology Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tej Singh ceased to be Director on 19 Feb 2021. Anish Verma was appointed as Director on 17 Feb 2021. Vinod Vijay was appointed as Director on 17 Feb 2021. Medill Pharma has 4 board changes on record in total.
The registered office of Medill Pharma is at 10131 Pratap Nagar Sanganer, Jaipur, Rajasthan, India – 302033.
Medill Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Medill Pharma can be reached at its registered office: 10131 Pratap Nagar Sanganer, Jaipur, Rajasthan, India – 302033.